Your search returned 2 results.

Results
	1.	A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia. [electronic resource] by Schliemann, Christoph Gerss, Joachim Wiebe, Stefanie Mikesch, Jan-Henrik Knoblauch, Nicola Sauer, Tim Angenendt, Linus Kewitz, Tobias Urban, Marc Butterfass-Bahloul, Trude Edemir, Sabine Vehring, Kerstin Müller-Tidow, Carsten Berdel, Wolfgang E Krug, Utz Producer: 20170620 In: PloS one vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML). [electronic resource] by Kessler, Torsten Koschmieder, Steffen Schliemann, Christoph Crysandt, Martina Mikesch, Jan-Henrik von Stillfried, Saskia Stelljes, Matthias Pohlen, Michele Lenz, Georg Kirsch, Anna Vehring, Kerstin Wardelmann, Eva Hartmann, Wolfgang Bormann, Eike Gerss, Joachim Brümmendorf, Tim H Müller-Tidow, Carsten Berdel, Wolfgang E Producer: 20190605 In: Annals of hematology vol. 98 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search